Abstract
Tenofovir alafenamide (TAF) is a newly developed prodrug of tenofovir (TFV). We divided 48 chronic hepatitis B patients who had taken entecavir (ETV) ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
